Www.spotsndots.com

The forecast assumes that effective vaccines will be widely available by mid-2021, although full availability is not expected until 2022. Full-year 2020 sales are expected to be down 15% from the levels achieved in 2019. IHS Markit remains cautious on recovery prospects, with key markets likely to experience differing demand cycles. ................
................